Atavistik Bio Announces $60 Million Series A Financing to Advance Genetically-Validated Targets in Metabolic Diseases and Cancer
Buyout giant Bain Capital has raised $1.9bn for its second life sciences-focused fund targeting pharma and biopharma, medical device and diagnostics deals. The post Bain Capital continues 2021 fundraising streak with hefty $1.9bn life science
SkyBridge Capital&`s SALT Conference is returning as an in-person event in New York from September 13-15. This year&`s event will focus on three main pillars FinTech/digital assets; healthcare and biotechnology, ...Article Link
SkyBridge Capital's SALT Conference is returning as an in-person event in New York from September 13-15. This year's event will focus on three main pillars FinTech/digital assets; healthcare and biotechnology, and ESG...Article Link
Inflexion is to acquire Sunovion Pharmaceuticals Europe (SPE) from US-based Sunovion Pharmaceuticals, according to a statement from parent company Sumitomo Dainippon Pharma.
Baring Private Equity Asia has agreed to acquire the healthcare services arm of India’s Hinduja Global Solutions for $1.2bn. The post Baring PE Asia to acquire Hinduja’s healthcare services arm for $1.2bn, seventh deal in
Mid-market buyout firm Palladium Equity Partners has acquired behavioural health service platform Health Connect America from Harren Equity Partners. The post Palladium backs Health Connect America to target geographic expansion first appeared on AltAssets Private
Healthcare focused private equity house Avista Capital Partners has agreed to sell consumer healthcare provider Arcadia Consumer Healthcare to investment firm Bansk Group. The post Avista Capital Partners to sell Arcadia Consumer Healthcare to Bansk
Technology and healthcare-focused buyout house Keensight Capital has agreed to exit portfolio company Demetra to AStorg after tripling the revenue of the company. The post Keensight Capital to exit Demetra after five years, boosts revenues
FSN Capital has acquired a majority stake in Adragos Pharma, a Germany-based B2B contract developer and manufacturer (CDMO) for pharmaceuticals.
A consortium led by private equity house CBC Group is said to be in advanced talks with Bain’s Capital to acquire its majority stake in Korean cosmetic pharmaceutical company Hugel Inc. The post CBC-led group
Healthcare-focused buyout house ArchiMed has closed its oversubscribed third fund on €650m despite receiving €1.3bn in the virtual raise. MED III has beat its target of €500m and doubled the size of its predecessor MED
